Relx N.V. (NYSE:RENX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday. The firm currently has a $24.00 target price on the technology company’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 12.52% from the stock’s current price.

According to Zacks, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands. “

Separately, BidaskClub cut Relx N.V. from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 10th.

Relx N.V. (NYSE RENX) opened at 21.33 on Friday. Relx N.V. has a 12-month low of $14.92 and a 12-month high of $21.37. The firm has a 50 day moving average of $20.93 and a 200 day moving average of $19.83. The firm has a market capitalization of $42.98 billion, a P/E ratio of 26.33 and a beta of 0.86.

COPYRIGHT VIOLATION NOTICE: “Relx N.V. (RENX) Lifted to Buy at Zacks Investment Research” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/09/09/relx-n-v-renx-lifted-to-buy-at-zacks-investment-research.html.

Institutional investors have recently made changes to their positions in the company. Morgan Stanley increased its position in shares of Relx N.V. by 69.5% during the 4th quarter. Morgan Stanley now owns 105,881 shares of the technology company’s stock valued at $1,781,000 after purchasing an additional 43,413 shares during the last quarter. Gilman Hill Asset Management LLC increased its position in shares of Relx N.V. by 6.9% during the 4th quarter. Gilman Hill Asset Management LLC now owns 38,502 shares of the technology company’s stock valued at $648,000 after purchasing an additional 2,480 shares during the last quarter. Comerica Bank increased its position in shares of Relx N.V. by 11.9% during the 4th quarter. Comerica Bank now owns 61,153 shares of the technology company’s stock valued at $1,028,000 after purchasing an additional 6,516 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Relx N.V. by 0.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 309,559 shares of the technology company’s stock valued at $5,210,000 after purchasing an additional 2,255 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in shares of Relx N.V. by 39.3% during the 4th quarter. Wells Fargo & Company MN now owns 413,179 shares of the technology company’s stock valued at $6,953,000 after purchasing an additional 116,633 shares during the last quarter. 1.07% of the stock is owned by hedge funds and other institutional investors.

About Relx N.V.

RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.

Get a free copy of the Zacks research report on Relx N.V. (RENX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Relx N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx N.V. and related companies with MarketBeat.com's FREE daily email newsletter.